Team Europe: EIB invests €100 million to support healthcare infrastructure in Georgia
The loan also covers the procurement of essential COVID-19-related medical equipment.
The operation is part of the EIB's €6.7 billion COVID-19 emergency response and part of the Team Europe support package to the EU partner countries during the pandemic.
The
The EIB loan guaranteed by the
The EIB financing will also cover the procurement of modern medical equipment and vaccines, and the establishment of an effective supply chain to provide comprehensive diagnostic and treatment services for COVID-19 patients.
The operation will enable the
Background information
About the EIB:
The
About the EIB and investments in vaccines, treatments and diagnostics for COVID-19:
To date, the EIB has invested €700 million in 20 European meditech and biotech companies working on vaccines, treatments or diagnostics for COVID-19. This includes a €100 million investment in BioNTech, the German company behind the Pfizer/BioNTech vaccine. Against the backdrop of the health crisis, this financing reflects the EIB's strong mobilisation to support the development of new and effective treatments for COVID-19. For more information, please contact the EIB Press Office.
The EIB in
Since the beginning of its operations in
The EIB finances most projects in
Copyright European Union, 1995-2020
SOURCE
US Negotiating For Millions More Vaccine Doses From Pfizer
Quiet Reaction to Stimulus Deal, Though NASDAQ Hits New High
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News